Office of Professional Education

A free CME live webinar

Atopic Dermatitis (AD) is a chronic and complex inflammatory skin condition affecting approximately 13% of children and 7% of adults in the US. The number of therapeutic agents for moderate-to-severe atopic dermatitis is growing rapidly. An increased understanding of current and emerging treatments as well as multidisciplinary strategies for coordination of care is critical for allergists and dermatologists to optimize patient care in moderate-to-severe AD. 

This engaging activity, led by allergy and dermatology experts who specialize in AD, will provide multidisciplinary real-world insights into considerations for diagnosis, treatment selection, and longitudinal management based on current and emerging therapies.

Dates and Times:

  • Thursday, May 20, 2021 – 5:30 pm to 6:30 pm MT 
    (Begins at 7:30 pm ET, 6:30 pm CT, and 4:30 pm PT)

  • Thursday, May 27, 2021 – 5:30 pm to 6:30 pm MT
    (Begins at 7:30 pm ET, 6:30 pm CT, and 4:30 pm PT)


► Register Now!

Target Audience:

Dermatologists and allergists, along with physician assistants and nurse practitioners who are involved in the care and treatment of patients with moderate-to-severe atopic dermatitis.


Learning Objectives:

Upon completion of this activity, the participant will be better able to:

  1. Evaluate current and emerging treatment options for patients with moderate-to-severe AD.
  2. Incorporate appropriate considerations, including co-morbidities and safety profiles, into treatment selection of moderate-to-severe AD.
  3. Develop multi-disciplinary strategies to select optimal treatment and improve continuity of care for patients with AD. 


Program Faculty:

Donald Y M Leung, MD, PhD (Program Chair)
Edelstein Chair of Pediatric Allergy-Immunology Professor
Head, Division of Pediatric Allergy and Immunology
Department of Pediatrics
National Jewish Health
Denver, CO

Cory A. Dunnick, MD
Director, Clinical Trials
Department of Dermatology
University of Colorado
Aurora, CO
Kanao Otsu, MD, MPH
Assistant Professor
Division of Allergy and Clinical Immunology
Department of Medicine
National Jewish Health
Denver, CO
Elizabeth Swanson, MD
Board Certified Dermatologist
Board Certified Pediatric Dermatologist
Ada West Dermatology
St. Luke’s Children’s Hospital
Boise, ID



For questions, please email the Office of Professional Education at National Jewish Health or call 303.398.1000 or 800.844.2305. To register, please click here.

Accreditation and Designation Statements:

Physicians:  National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

National Jewish Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 


This educational activity is supported by an independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.